Use your browser's back button to choose another title or click here for a New Search.

How to Get the Article

 Email CTN Library (free)

PubMed Central (free)

Journal subscriber access


Bookmark and Share




Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients.

AIDS and Behavior 2016;20(1):204-214. [doi: 10.1007/s10461-015-1074-2]

Diana Hernández, PhD (Columbia University, FNA Node), Daniel J. Feaster, PhD (Miller School of Medicine, University of Miami, FNA Node), Lauren K. Gooden, PhD, MPH (University of Miami, Columbia University, FNA Node), Antoine B. Douaihy, MD (University of Pittsburgh Medical Center, OV Node), Raul N. Mandler, MD (Center for the Clinical Trials Network, NIDA), Sarah J. Erickson, PhD (University of New Mexico, SW Node), Tiffany L. Kyle, PhD (The Center for Drug Free Living, FNA Node), Louise F. Haynes, MSW (Medical University of South Carolina, SC Node), Robert P. Schwartz, MD (Friends Research Institute, Inc., MA Node), Moupali Das, MD, MPH (San Francisco Department of Public Health, WS Node), Lisa R. Metsch, PhD (Columbia University, FNA Node).

Substance users are at increased risk for HIV and HCV infection. Still, many substance use treatment programs (SUTP) fail to offer HIV/HCV testing. This secondary analysis of data from the National Drug Abuse Treatment Clinical Trials Network study CTN-0032, a multi-site randomized trial of rapid HIV testing, examines self-reported HIV/HCV testing patterns and serostatus of 2473 SUTP patients in 12 community-based sites that had not previously offered on-site testing. Results indicate that most respondents screened for the randomized trial tested more than a year prior to intake for HIV (52%) and HCV (38%). Prevalence rates were 3.6 and 30% for HIV and HCV, respectively. The majority of participants that were HIV (52.2%) and HCV-positive (40.5%) reported having been diagnosed within the last 1-5 years. Multivariable logistic regression showed that members of high-risk groups were more likely to have been tested.

Conclusions: This analysis demonstrates the potential for community-based substance use treatment programs to identify substance users at-risk for HIV and HCV infection. Access to high quality care and service attentive to the unique needs of substance users is vital to realizing optimal results in both HIV and HCV, reducing the incidence of late diagnosis, extending life expectancy, improving health outcomes and overall quality of life, and decreasing the use of costly medical services. Bundled HIV/HCV testing and linkage to care issues are recommended for expanding testing in community-based SUTP settings. (Article (Peer-Reviewed), PDF, English, 2015)

Keywords: Community health services | CTN platform/ancillary study | Hepatitis C | HIV/AIDS | HIV rapid testing | Sexually transmitted diseases | AIDS and Behavior (journal)

Document No: 145, PMID: 25952768, PMCID: PMC4637257.

Submitted by CTN Dissemination Librarians, 5/12/2015.


Das, Moupali mail
Douaihy, Antoine B. mail
Erickson, Sarah J.
Feaster, Daniel J. mail
Gooden, Lauren K. mail
Haynes, Louise F. search mail
Hernández, Diana search mail
Kyle, Tiffany L. search mail
Mandler, Raul N. search mail
Metsch, Lisa R. search mail
Schwartz, Robert P. search mail
NIDA-CTN-0032 www
Florida Node Alliance (Lead) www
Appalachian Tri-State www
Mid-Atlantic www
New England Consortium www
Ohio Valley www
Southern Consortium www
Southwest www
Western States www

dark blue line
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 1/2017 --
dark blue line